Med by Cell Press

1K posts

Med by Cell Press banner
Med by Cell Press

Med by Cell Press

@MedCellPress

Medical journal publishing research with immediate impact on clinical practice and health policy. This account is not monitored, and content is automated.

Katılım Aralık 2019
164 Takip Edilen12.9K Takipçiler
Sabitlenmiş Tweet
Med by Cell Press
Med by Cell Press@MedCellPress·
We are turning this account into a fully automated page. To learn more of what’s going on in our journal, follow us on LinkedIn: linkedin.com/company/med-ce…
Med by Cell Press tweet media
English
1
0
0
1.5K
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Deep multi-omics profiling reveals three molecular subtypes of chronic obstructive pulmonary disease in a unique biomass-exposed Chinese population dlvr.it/TRLKM1
English
0
0
1
189
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: T cell exhaustion in bi- and trispecific T cell engager therapy in hematologic malignancies: Mechanisms and implications dlvr.it/TRFJrM
English
0
0
0
177
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Precise and efficient DNA base editing restores normal hearing in adult DFNB9 mouse model dlvr.it/TRCl3f
English
0
0
0
237
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: A machine learning model integrating circulating Temra cell transcriptional profiles to predict immunotherapy efficacy dlvr.it/TRC8TY
English
0
1
1
235
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy dlvr.it/TR9kCH
English
0
2
4
220
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Health care utilization and self-reported health status among US cancer survivors by rurality and area deprivation dlvr.it/TR555y
English
0
2
1
169
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial dlvr.it/TR4VqH
English
0
1
1
175
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: COPD reshapes the tumor microenvironment of NSCLC and enhances anti-PD-1 therapy response dlvr.it/TQzpj8
English
0
0
0
147
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma dlvr.it/TQyKpN
English
0
1
0
163
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Toward precision immunotherapy: In vivo gene editing of T, NK, and myeloid cells dlvr.it/TQxkqF
English
0
0
0
154
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Analysis of biomarkers in the Human Phenotype Project using disease models from UK Biobank dlvr.it/TQw9mm
English
0
0
0
133
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: The diversity of emerging tick-borne viruses globally: From discoveries to zoonotic risk assessment dlvr.it/TQvBdj
English
0
0
1
121
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Adjunctive intravenous tirofiban plus methylprednisolone for acute ischemic stroke: A pooled analysis of the RESCUE BT and MARVEL trials dlvr.it/TQtNNN
English
0
2
0
165
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Incidence and spectrum of immune-related adverse events in nasopharyngeal carcinoma patients treated with immune checkpoint inhibitors dlvr.it/TQrq45
English
0
0
0
126
Med by Cell Press
Med by Cell Press@MedCellPress·
Join us in celebrating Med’s commitment to advancing research, embracing technological innovation, and fostering meaningful relationships at the heart of medicine with a selection of inspiring commentaries from Med’s advisory board members. 👉 hubs.li/Q040RldG0
Med by Cell Press tweet media
English
0
0
2
111
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis dlvr.it/TQqD1m
English
0
0
0
187
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Advances and perspectives in CEA-targeted therapies: From classic biomarker toward actionable therapeutic target dlvr.it/TQpYBL
English
0
1
1
173
Med by Cell Press
Med by Cell Press@MedCellPress·
Online Now: Bridge to transplant using a flow-adaptive extracorporeal total artificial lung system following bilateral pneumonectomy dlvr.it/TQjHsb
English
0
0
1
141